Oxilofrine

Oxilofrine

SCHEMBL14153976

CN[C@@H](C)[C@H](O)c1ccc(O)cc1

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRA1A P35348 5/20 0.67
▸ CYP2D6 P10635 4/20 0.67
▸ CYP2C19 P33261 3/20 0.67
▸ CYP3A4 P08684 2/20 0.67
▸ TSHR P16473 2/20 0.67
▸ ADRA2C P18825 2/20 0.67
▸ NFKB1 P19838 2/20 0.67
▸ HTR2A P28223 2/20 0.67
▸ CYP2C9 P11712 2/20 0.67
▸ THPO P40225 2/20 0.67
▸ CHRM2 P08172 1/20 0.67
▸ RGS12 O14924 1/20 0.67
▸ GLA P06280 1/20 0.67
▸ PKM P14618 1/20 0.67
▸ ALOX15 P16050 1/20 0.67
▸ ALOX12 P18054 1/20 0.67
▸ GNAI1 P63096 1/20 0.67
▸ HSD17B10 Q99714 1/20 0.67
▸ KMT2A Q03164 3/20 0.64
▸ MEN1 O00255 2/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxilofrine SCHEMBL14465574 1.00 ADRA1A (0.67) ADRA1ACYP2D6CYP2C19CYP3A4TSHR
Oxilofrine SCHEMBL4256893 1.00 ADRA1A (0.67) ADRA1ACYP2D6CYP2C19CYP3A4TSHR
Oxilofrine SCHEMBL147458 1.00 ADRA1A (0.67) ADRA1ACYP2D6CYP2C19CYP3A4TSHR
Oxilofrine SCHEMBL5173040 1.00 ADRA1A (0.67) ADRA1ACYP2D6CYP2C19CYP3A4TSHR
Oxilofrine SCHEMBL5174274 0.98 KMT2A (0.68) ADRA1ACYP2D6CYP2C19CYP3A4TSHR
Oxilofrine SCHEMBL29354826 0.98 KMT2A (0.68) ADRA1ACYP2D6CYP2C19CYP3A4TSHR
SCHEMBL23999268 0.83 CYP2D6 (0.67) ADRA1ACYP2D6CYP2C19CYP3A4TSHR
SCHEMBL20690347 0.83 HIF1A (0.56) ADRA1ACYP2D6CYP2C19CYP3A4TSHR
SCHEMBL23999280 0.83 CYP2D6 (0.67) ADRA1ACYP2D6CYP2C19CYP3A4TSHR
Oxilofrine SCHEMBL15347269 0.82 TAAR1 (0.65) ADRA1ACYP2D6CYP2C19CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7396954-B2 Intermediates in producing phenoxyacetic acid preventives and method of using the same KISSEI PHARMACEUTICAL CO., LTD. (JP) 2008-07-08 — — US disclosed
US-20080045740-A1 INTERMEDIATES IN PRODUCING PHENOXYACETIC ACID PREVENTIVES AND METHOD OF USING THE SAME KISSEI PHARMACEUTICAL CO., LTD. (JP) 2008-02-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045740-A1 INTERMEDIATES IN PRODUCING PHENOXYACETIC ACID PREVENTIVES AND METHOD OF USING THE SAME ADRB3, PAH, SLC10A2 ADRA1A 4/4885CYP2D6 588/4885CYP2C19 443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback